:
Neglected parasitic diseases are a group of infections currently considered as a worldwide concern. This fact
can be attributed to the migration of these diseases to developed and developing countries, associated with therapeutic
insufficiency resulted from the low investment in the research and development of new drugs. In order to overcome this
situation, bioprospecting supports medicinal chemistry in the identification of new scaffolds with therapeutically
appropriate physicochemical and pharmacokinetic properties. Among them, we highlight the nitrogenous heterocyclic
compounds, as they are secondary metabolites of many natural products with potential biological activity. The objective
of this work was to review studies within a 10 year timeframe (2009-2019), focusing on the pharmacological application
of nitrogen bioprospectives (pyrrole, pyridine, indole, quinoline, acridine, and their respective derivatives) against
neglected parasitic infections (malaria, leishmania, trypanosomiases, and schistosomiasis), and their application as a
template for semi-synthesis or total synthesis of potential antiparasitic agents. In our studies, it was observed that among
the selected articles, there was a higher focus on the attempt to identify and obtain novel antimalarial compounds, in a
way that an extensive amount of studies involving all heterocyclic nitrogen nuclei were found. On the other hand, the
parasites with the lowest number of publications up until the present date have been trypanosomiasis, especially those
caused by Trypanosoma cruzi, and schistosomiasis, where some heterocyclics have not even been cited in recent years.
Thus, we conclude that despite the great biodiversity on the planet, little attention has been given to certain neglected
tropical diseases, especially those that reach countries with a high poverty rate.